Display options
Cite
Baum C, Soliman AS, Brown HE, et al. Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period. J Cancer Epidemiol. 2020;2020:6031708doi: 10.1155/2020/6031708.
Baum, C., Soliman, A. S., Brown, H. E., Seifeldin, I. A., Ramadan, M., Lott, B., Nguyen, A., El-Ghawalby, A., & Hablas, A. (2020). Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period. Journal of cancer epidemiology, 20206031708. https://doi.org/10.1155/2020/6031708
Baum, Christina, et al. "Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period." Journal of cancer epidemiology vol. 2020 (2020): 6031708. doi: https://doi.org/10.1155/2020/6031708
Baum C, Soliman AS, Brown HE, Seifeldin IA, Ramadan M, Lott B, Nguyen A, El-Ghawalby A, Hablas A. Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period. J Cancer Epidemiol. 2020 Jul 14;2020:6031708. doi: 10.1155/2020/6031708. eCollection 2020. PMID: 32733561; PMCID: PMC7376424.
Copy Download .nbib Format: NLM
Share it on

J Cancer Epidemiol. 2020 Jul 14;2020:6031708. doi: 10.1155/2020/6031708. eCollection 2020.

Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period.

Journal of cancer epidemiology

Christina Baum, Amr S Soliman, Heidi E Brown, Ibrahim A Seifeldin, Mohamed Ramadan, Breanne Lott, An Nguyen, Ahmed El-Ghawalby, Ahmed Hablas

Affiliations

  1. Department of Epidemiology & Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ 85724, USA.
  2. Department of Community Health and Social Medicine, City University of New York Medical School, New York City, NY 10031, USA.
  3. Gharbiah Cancer Society, Tanta, Gharbiah, Egypt.
  4. Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ 85724, USA.
  5. Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC 20052, USA.
  6. Department of Surgery, Liver Transplantation Unit, Gastrointestinal Surgery Center, College of Medicine, Mansoura University, Mansoura, Egypt.

PMID: 32733561 PMCID: PMC7376424 DOI: 10.1155/2020/6031708

Abstract

BACKGROUND: Pancreatic cancer is one of the deadliest forms of cancer, with incidence rates rising in many countries around the world. Geographic variation in pancreatic cancer incidence has not been studied extensively, especially in low- and middle-income countries. The aim of this study was to characterize the distribution of pancreatic cancer incidence in the central Nile Delta region of Egypt and to examine differences by urban and rural patient residence using the nation's only population-based cancer registry.

METHODS: Utilizing the Gharbiah province population-based cancer registry, data were abstracted for 1,089 pancreatic cancer cases diagnosed over twelve years from 1999 to 2010. Age- and sex-specific incidence rates were calculated and compared for urban and rural areas of the eight districts of Gharbiah.

RESULTS: Age-adjusted incidence of pancreatic cancer within Gharbiah varied considerably by urban/rural patient residence and by district. Incidence rates were 1.3 times higher in urban compared to rural areas (4.45 per 100,000 in urban areas and 3.43 per 100,000 in rural areas). The highest incidence rates were observed in urban centers of Kotour, El Santa, and Kafr El-Zayat districts (12.94, 8.32, and 7.89, respectively).

CONCLUSION: Incidence rates varied greatly by urban and rural areas and by district of residence in the Nile Delta region of Egypt. Future studies should examine potential environmental risk factors that may contribute to the geographic distribution of pancreatic cancer in this region.

Copyright © 2020 Christina Baum et al.

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

References

  1. Mol Carcinog. 2012 Jan;51(1):98-108 - PubMed
  2. Pancreas. 2018 Feb;47(2):233-237 - PubMed
  3. Sci Rep. 2017 Jun 9;7(1):3165 - PubMed
  4. East Mediterr Health J. 2018 May 03;24(2):198-215 - PubMed
  5. Pancreas. 2007 Aug;35(2):120-9 - PubMed
  6. J Relig Health. 2012 Dec;51(4):1216-25 - PubMed
  7. Cancer Med. 2016 Jan;5(1):100-10 - PubMed
  8. Int J Cancer. 2016 Dec 1;139(11):2436-46 - PubMed
  9. Cancer Epidemiol. 2016 Oct;44:195-202 - PubMed
  10. World J Gastroenterol. 2016 Nov 28;22(44):9694-9705 - PubMed
  11. Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):529-536 - PubMed
  12. Health Econ Policy Law. 2009 Oct;4(Pt 4):445-78 - PubMed
  13. Am J Ind Med. 1999 Aug;36(2):239-47 - PubMed
  14. Bull Environ Contam Toxicol. 1995 Aug;55(2):258-63 - PubMed
  15. Eur J Epidemiol. 2010 Oct;25(10):721-30 - PubMed
  16. Pancreas. 2017 May/Jun;46(5):699-706 - PubMed
  17. Int J Health Geogr. 2007 Jul 26;6:34 - PubMed
  18. Cancer Detect Prev. 2006;30(5):473-9 - PubMed
  19. Ann Oncol. 2012 Jul;23(7):1880-8 - PubMed
  20. Dig Dis. 2010;28(4-5):645-56 - PubMed
  21. Int J Cancer. 1997 Jul 3;72(1):62-7 - PubMed
  22. Rev Environ Health. 1999 Jan-Mar;14(1):39-50 - PubMed
  23. Jpn J Clin Oncol. 1985 Jun;15(2):403-13 - PubMed
  24. J Med Genet. 1996 Nov;33(11):889-98 - PubMed
  25. Carcinogenesis. 2007 Aug;28(8):1794-9 - PubMed
  26. Cancer Causes Control. 2015 Nov;26(11):1583-91 - PubMed
  27. J Environ Public Health. 2012;2012:180186 - PubMed
  28. Ann Glob Health. 2015 Nov-Dec;81(6):814-20 - PubMed
  29. CA Cancer J Clin. 2018 Nov;68(6):394-424 - PubMed
  30. Diabet Med. 1995 Dec;12(12):1126-31 - PubMed
  31. Asian Pac J Cancer Prev. 2018 Feb 26;19(2):449-455 - PubMed
  32. Chin J Cancer Res. 2015 Feb;27(1):2-12 - PubMed
  33. Environ Health Perspect. 2006 Jan;114(1):113-9 - PubMed

Publication Types